Business
biOasis Announces Shares for Services Settlement
biOasis Announces Shares for Services Settlement.
About this update from Bioasis Technologies Inc.
[{"type":"text","content":"\nbiOasis Announces Shares for Services Settlement \n\nbiOasis Announces Shares for Services Settlement\n\n\n VANCOUVER, BC --(Marketwired - February 29, 2016) - biOasis Technologies Inc. (TSX VENTURE: BTI) (OTCQB: BIOAF) (the \"Company\") wishes to announce its intention to issue 125,000 shares for services to a consultant of the Company that provides certain consulting services related to business development and financial advisory services. The issuance of shares for services will represent payment of consulting fees. The consulting agreement provides that consulting fee, or any portion thereof, can be converted to common shares. The transaction is subject to TSX-V approval. In accordance with the applicable securities laws, the shares to be issued will be subject to a 4-month-plus-1-day hold period from the date of issuance.\n About biOasisbiOasis Technologies Inc. is a biopharmaceutical company headquartered in Vancouver, Canada. Based on Transcend, biOasis proprietary brain delivery platform, the company is focused on creating new drugs that can cross the BBB to address unmet medical needs in the treatment of brain diseases such as neurodegeneration, metastatic cancer and metabolic diseases. biOasis trades on the OTCQB under the symbol \"BIOAF\" and on the TSX Venture Exchange under the symbol \"BTI\". For more information about the company please visit www.bioasis.ca.\n Forward Looking StatementsCertain statements in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities legislation that may not be based on historical fact, including without limitation statements containing the words \"believe\", \"may\", \"plan\", \"will\", \"estimate\", \"continue\", \"anticipate\", \"intend\", \"expect\" and similar expressions. Such forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause our actual results, events or developments, or industry results, to be materially different from any future results, events or developments express or implied by such forward-looking statements or information. Such factors include, among others, our stage of development, lack of any product revenues, additional capital requirements,...